Skip to main content

Toronto Microarray Facility to Use Inforsense Analysis Software

NEW YORK, July 13 (GenomeWeb News) - InforSense said today that it has signed a software licensing agreement with the Center for Applied Genomics Microarray Facility at the Hospital for Sick Children in Toronto, Canada.

 

The facility has purchased a multi-user, multi-year license for the company's Knowledge Discovery Environment informatics system to analyze data from the Affymetrix GeneChip platform, Inforsense said.

 

Financial terms of the agreement were not provided.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.